A new study suggests that the composition of hormone replacement therapy is a factor in determining whether it increases the risk of breast cancer recurrence. 

In a recent clinical trial, carried out in Sweden, it was learned that hormone replacement therapy (HRT) taken to reduce menopausal symptoms can increase the risk of breast cancer recurrence.

In a new study from Sweden, researchers at the Karolinska Institute reveal how there was no obvious link between hormone therapy and breast cancer recurrence.

It may be differences in composition of the hormone therapy which explain why sometimes there is a risk and sometimes not. The timing of the therapy may also have an effect.

The challenge now is to carry out further studies to see what kind of hormone therapy women with breast cancer can take so they do not increase their risk of a recurrence. There is a clear need for a safe form of hormone replacement for relieving menopausal symptoms.



We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.


Continuing the battle with Big Pharma

The entire Beasley Allen staff had our personal interest at heart. We were part of the family of a down to earth, trustworthy, understanding law firm. Thank you, Beasley Allen, for continuing the battle with Big Pharma.

—Richard